TerminatedPhase 3Phase 4ACTRN12611000387921

The role of intravenous iron for patients with anaemia around the time of surgery

The role of intravenous iron compared to standard treatment for patients booked for major abdominal surgery with anaemia around the time of surgery in reduction in allogeneic red cell transfusion".


Sponsor

Lyell McEwin Hospital

Enrollment

136 participants

Start Date

Aug 27, 2011

Study Type

Interventional

Conditions

Summary

investigators decided to decline the sponsorship offer.


Eligibility

Sex: Both males and femalesMin Age: 18 Yearss

Plain Language Summary

Simplified for easier understanding

This study tests whether giving intravenous iron before or around the time of surgery can help patients with anaemia (low blood levels). It is for adults aged 18 and over with low haemoglobin and iron levels who do not have other causes of anaemia such as vitamin deficiencies or bleeding disorders.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Patients randomized to the intervention group will be exposed to intravenenous admistration of Ferric carboxymaltose before (1000mg or max 15mg /kg) and after surgery (50mg per 100ml estimated blood l

Patients randomized to the intervention group will be exposed to intravenenous admistration of Ferric carboxymaltose before (1000mg or max 15mg /kg) and after surgery (50mg per 100ml estimated blood loss)


Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12611000387921


Related Trials